Low doses of amitriptyline, pregabalin, and gabapentin are preferred for management of neuropathic pain in India: is there a need for revisiting dosing recommendations?

por Kamble, Sanjay Vasant, Motlekar, Salman Abdulrehman, D'souza, Lyndon Lincoln, Kudrigikar, Vinay Nanda, Rao, Sameer Eknath
Publicado 2017